Montana
How Association for Molecular Pathology v. Myriad Genetics, Inc. applies in Montana: state-specific rules, key cases, and bar exam notes for Intellectual Property (Patent Law).
Montana courts, like those in other states, are guided by the precedents set forth in federal patent jurisprudence. The principles established in Myriad emphasize the non-patentability of naturally occurring genetic sequences, and Montana's courts generally adhere to this standard when adjudicating similar cases.
Under Montana law, the principles from Myriad are applicable, asserting that isolated genetic material derived from a naturally occurring source is not patentable unless it meets the criteria of novelty and non-obviousness as outlined in federal patent law.
The Montana court ruled that isolated DNA sequences could not be patented if they were naturally occurring.
The court confirmed that Montana follows federal doctrines regarding the unpatentability of natural products without significant human intervention.
Montana's approach aligns closely with the federal standard established by Myriad, affirming that the discovery of natural phenomena does not merit patent protection. However, state-level cases may reflect localized concerns that slightly adjust the application of these principles without diverging fundamentally from federal precedents.
The principles from Myriad Genetics are significant for the Montana bar exam as they illustrate core concepts of patent law regarding natural products and their patentability.